Publication:
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

Simple item page
dc.contributor.authorsDirican E.
dc.date.accessioned2022-03-15T02:11:36Z
dc.date.accessioned2026-01-11T08:03:30Z
dc.date.available2022-03-15T02:11:36Z
dc.date.issued2016
dc.description.abstract[No abstract available]
dc.identifier.doi10.7314/APJCP.2016.17.5.2731
dc.identifier.issn15137368
dc.identifier.pubmed27268661
dc.identifier.urihttps://hdl.handle.net/11424/247682
dc.language.isoeng
dc.publisherAsian Pacific Organization for Cancer Prevention
dc.relation.ispartofAsian Pacific Journal of Cancer Prevention
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleMutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
dc.typeother
dc.type.subletter
dspace.entity.typePublication
oaire.citation.issue5
oaire.citation.startPage2731
oaire.citation.titleAsian Pacific Journal of Cancer Prevention
oaire.citation.volume17

Files

Collections

Araştırma Çıktıları